Drugs / inactivated poliovirus vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT04063150 Comparator | Oct 2019 → Mar 2020 | poliomyelitis | Centers for Disease Control and Prevention | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | inactivated poliovirus vaccine | “Full dose of inactivated poliovirus vaccine that protects against types 1, 2, and 3 (all polio serotypes).” NCT04063150 ↗ |
| Known as | IPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04063150 ↗ |
| Modality | Vaccine | “inactivated poliovirus vaccine” NCT04063150 ↗ |